#170 ILD and High-Risk Medication Prescribing: Gray Matters Segment
Core IM | Internal Medicine Podcast
Understanding Antifibrotic Medications for ILD
This chapter explores antifibrotic medications for progressive fibrotic lung disease, specifically focusing on Esbriate and Ofev. It discusses their role in managing interstitial lung disease (ILD), the importance of monitoring liver function, and highlights the cautious use of immunosuppressants, especially in idiopathic pulmonary fibrosis (IPF). The chapter wraps up with insights into the diagnostic process of interstitial pneumonia and the challenges associated with treatment planning.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
